Form 4 holding
Chief Operating Officer and Chief Legal Officer
AN2 Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 207,546
- Estimated value
- $875,844
- Report date
- 05 Nov 2026
- Price
- $4.22
- Ownership
- Direct